These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 10464279)

  • 1. alpha-synuclein binds to Tau and stimulates the protein kinase A-catalyzed tau phosphorylation of serine residues 262 and 356.
    Jensen PH; Hager H; Nielsen MS; Hojrup P; Gliemann J; Jakes R
    J Biol Chem; 1999 Sep; 274(36):25481-9. PubMed ID: 10464279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular co-localization of phosphorylated tau- and NACP/alpha-synuclein-epitopes in lewy bodies in sporadic Parkinson's disease and in dementia with Lewy bodies.
    Arima K; Hirai S; Sunohara N; Aoto K; Izumiyama Y; Uéda K; Ikeda K; Kawai M
    Brain Res; 1999 Oct; 843(1-2):53-61. PubMed ID: 10528110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parkinsonian neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and alpha-synuclein mutations promote Tau protein phosphorylation at Ser262 and destabilize microtubule cytoskeleton in vitro.
    Qureshi HY; Paudel HK
    J Biol Chem; 2011 Feb; 286(7):5055-68. PubMed ID: 21127069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colocalization of tau and alpha-synuclein epitopes in Lewy bodies.
    Ishizawa T; Mattila P; Davies P; Wang D; Dickson DW
    J Neuropathol Exp Neurol; 2003 Apr; 62(4):389-97. PubMed ID: 12722831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Active, phosphorylation-dependent mitogen-activated protein kinase (MAPK/ERK), stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK), and p38 kinase expression in Parkinson's disease and Dementia with Lewy bodies.
    Ferrer I; Blanco R; Carmona M; Puig B; Barrachina M; Gómez C; Ambrosio S
    J Neural Transm (Vienna); 2001; 108(12):1383-96. PubMed ID: 11810403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Constitutive phosphorylation of the Parkinson's disease associated alpha-synuclein.
    Okochi M; Walter J; Koyama A; Nakajo S; Baba M; Iwatsubo T; Meijer L; Kahle PJ; Haass C
    J Biol Chem; 2000 Jan; 275(1):390-7. PubMed ID: 10617630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraneuronal filamentous tau protein and alpha-synuclein deposits in neurodegenerative diseases.
    Goedert M; Jakes R; Crowther RA; Hasegawa M; Smith MJ; Spillantini MG
    Biochem Soc Trans; 1998 Aug; 26(3):463-71. PubMed ID: 9765897
    [No Abstract]   [Full Text] [Related]  

  • 8. Tau phosphorylation increases in symptomatic mice overexpressing A30P alpha-synuclein.
    Frasier M; Walzer M; McCarthy L; Magnuson D; Lee JM; Haas C; Kahle P; Wolozin B
    Exp Neurol; 2005 Apr; 192(2):274-87. PubMed ID: 15755545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synucleins are a novel class of substrates for G protein-coupled receptor kinases.
    Pronin AN; Morris AJ; Surguchov A; Benovic JL
    J Biol Chem; 2000 Aug; 275(34):26515-22. PubMed ID: 10852916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. alpha-Synuclein is phosphorylated in synucleinopathy lesions.
    Fujiwara H; Hasegawa M; Dohmae N; Kawashima A; Masliah E; Goldberg MS; Shen J; Takio K; Iwatsubo T
    Nat Cell Biol; 2002 Feb; 4(2):160-4. PubMed ID: 11813001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. alpha-Synuclein and its disease-related mutants interact differentially with the microtubule protein tau and associate with the actin cytoskeleton.
    Esposito A; Dohm CP; Kermer P; Bähr M; Wouters FS
    Neurobiol Dis; 2007 Jun; 26(3):521-31. PubMed ID: 17408955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha-synuclein phosphorylation controls neurotoxicity and inclusion formation in a Drosophila model of Parkinson disease.
    Chen L; Feany MB
    Nat Neurosci; 2005 May; 8(5):657-63. PubMed ID: 15834418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From genetics to pathology: tau and alpha-synuclein assemblies in neurodegenerative diseases.
    Goedert M; Spillantini MG; Serpell LC; Berriman J; Smith MJ; Jakes R; Crowther RA
    Philos Trans R Soc Lond B Biol Sci; 2001 Feb; 356(1406):213-27. PubMed ID: 11260802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Demonstration of a role for alpha-synuclein as a functional microtubule-associated protein.
    Alim MA; Ma QL; Takeda K; Aizawa T; Matsubara M; Nakamura M; Asada A; Saito T; Kaji H; Yoshii M; Hisanaga S; Uéda K
    J Alzheimers Dis; 2004 Aug; 6(4):435-42; discussion 443-9. PubMed ID: 15345814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. α-Synuclein Fibrils Exhibit Gain of Toxic Function, Promoting Tau Aggregation and Inhibiting Microtubule Assembly.
    Oikawa T; Nonaka T; Terada M; Tamaoka A; Hisanaga S; Hasegawa M
    J Biol Chem; 2016 Jul; 291(29):15046-56. PubMed ID: 27226637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. More than just two peas in a pod: common amyloidogenic properties of tau and alpha-synuclein in neurodegenerative diseases.
    Lee VM; Giasson BI; Trojanowski JQ
    Trends Neurosci; 2004 Mar; 27(3):129-34. PubMed ID: 15036877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-localization of alpha-synuclein and phosphorylated tau in neuronal and glial cytoplasmic inclusions in a patient with multiple system atrophy of long duration.
    Piao YS; Hayashi S; Hasegawa M; Wakabayashi K; Yamada M; Yoshimoto M; Ishikawa A; Iwatsubo T; Takahashi H
    Acta Neuropathol; 2001 Mar; 101(3):285-93. PubMed ID: 11307630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Filamentous nerve cell inclusions in neurodegenerative diseases: tauopathies and alpha-synucleinopathies.
    Goedert M
    Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1101-18. PubMed ID: 10434313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding of alpha-synuclein to brain vesicles is abolished by familial Parkinson's disease mutation.
    Jensen PH; Nielsen MS; Jakes R; Dotti CG; Goedert M
    J Biol Chem; 1998 Oct; 273(41):26292-4. PubMed ID: 9756856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphorylation of tau and alpha-synuclein in synaptic-enriched fractions of the frontal cortex in Alzheimer's disease, and in Parkinson's disease and related alpha-synucleinopathies.
    Muntané G; Dalfó E; Martinez A; Ferrer I
    Neuroscience; 2008 Apr; 152(4):913-23. PubMed ID: 18343584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.